MX2022003090A - Vacuna combinada para ser administrable intradermicamente. - Google Patents

Vacuna combinada para ser administrable intradermicamente.

Info

Publication number
MX2022003090A
MX2022003090A MX2022003090A MX2022003090A MX2022003090A MX 2022003090 A MX2022003090 A MX 2022003090A MX 2022003090 A MX2022003090 A MX 2022003090A MX 2022003090 A MX2022003090 A MX 2022003090A MX 2022003090 A MX2022003090 A MX 2022003090A
Authority
MX
Mexico
Prior art keywords
mhyo
pcv2
combination vaccine
relates
intradermal administration
Prior art date
Application number
MX2022003090A
Other languages
English (en)
Inventor
Theodorus Jansen
Maarten Hendrik Witvliet
Melanie Sno
Martin Piest
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of MX2022003090A publication Critical patent/MX2022003090A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Abstract

La presente invención se refiere al campo de la vacunología veterinaria, a saber, a vacunas combinadas para cerdos. En términos particulares, la invención se refiere a una vacuna combinada para la protección contra una infección patógena con circovirus porcino tipo 2 (PCV2) y Mycoplasma hyopneumoniae (Mhyo) que comprende un inmunógeno no replicante de PCV2 e inmunógeno no replicante de Mhyo. La vacuna se caracteriza porque es una emulsión de aceite en agua que comprende escualano, vitamina E-acetato y sílice. En otra modalidad, la invención se refiere a una vacuna combinada para la protección contra una infección patógena con PCV2 y Mhyo mediante administración intradérmica.
MX2022003090A 2019-09-12 2020-09-11 Vacuna combinada para ser administrable intradermicamente. MX2022003090A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19196890 2019-09-12
PCT/EP2020/075454 WO2021048338A1 (en) 2019-09-12 2020-09-11 Combination vaccine for intradermal administration

Publications (1)

Publication Number Publication Date
MX2022003090A true MX2022003090A (es) 2022-04-11

Family

ID=68136125

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022003090A MX2022003090A (es) 2019-09-12 2020-09-11 Vacuna combinada para ser administrable intradermicamente.

Country Status (9)

Country Link
US (1) US20220323567A1 (es)
EP (1) EP4028050A1 (es)
JP (1) JP2022548001A (es)
KR (1) KR20220062345A (es)
CN (1) CN114364398A (es)
BR (1) BR112022004256A2 (es)
CA (1) CA3149027A1 (es)
MX (1) MX2022003090A (es)
WO (1) WO2021048338A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023118553A1 (en) 2021-12-24 2023-06-29 Intervet International B.V. Stable emulsions of antigens

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5106398B2 (ja) 2005-09-09 2012-12-26 インターベツト・インターナシヨナル・ベー・ベー Ｐｃｖ−２ワクチン
MX338626B (es) 2005-12-29 2016-04-26 Boehringer Ingelheim Vetmed Uso de una composicion inmunogenica de pcv2 para producir los sintomas clinicos en cerdos.
PT2481420T (pt) 2006-12-15 2019-05-31 Boehringer Ingelheim Animal Health Usa Inc Vacina para porcos anti-pcv2 de dose única
JP6907227B2 (ja) * 2016-03-23 2021-07-21 インターベット インターナショナル ベー． フェー． Ｐｃｖ２ウイルス及びマイコプラズマ・ハイオニューモニエ感染症に対する混合ワクチン
PL3558351T3 (pl) * 2016-12-23 2022-03-21 Intervet International B.V. Szczepionka skojarzona dla świń
EP3727432A1 (en) * 2017-12-22 2020-10-28 Hipra Scientific, S.L.U. Intradermal combination vaccine against mycoplasma and porcine circovirus

Also Published As

Publication number Publication date
WO2021048338A1 (en) 2021-03-18
US20220323567A1 (en) 2022-10-13
BR112022004256A2 (pt) 2022-06-21
CN114364398A (zh) 2022-04-15
JP2022548001A (ja) 2022-11-16
EP4028050A1 (en) 2022-07-20
CA3149027A1 (en) 2021-03-18
KR20220062345A (ko) 2022-05-16

Similar Documents

Publication Publication Date Title
MX2019007349A (es) Vacuna combinada para cerdos.
ME01000B (me) Živa vakcina avirulentne mycoplasma hyopneumoniae sa adjuvansom
MX2010007815A (es) Composiciones inmunogenicas de mycoplasma hyopneumoniae contra pcv2 y metodos para producir composiciones de este tipo.
CL2010000397A1 (es) Composicion que provee inmunidad protectora contra micoplasma hyopneumoniae que comprende una cantidad inmunizante de dicha bacteria, al menos otro antigeno viral o bacteriano, un adyuvante y un vehiculo farmaceutico, util para lograr proteccion inmune en animales. (divisional de solicitud 2003-00957)
BR112021024491A8 (pt) Composição imunogênica, e, método para prevenir, tratar ou melhorar uma infecção, doença ou condição
NZ591950A (en) Use of various antigens including antigens from mycoplasma bovis in multivalent vaccine composition
AR108829A1 (es) Vacuna contra virus de bronquitis infecciosa
PE20211545A1 (es) Dosis unitaria de vacuna contra el dengue y administracion de esta
MX2022003090A (es) Vacuna combinada para ser administrable intradermicamente.
RU2018127403A (ru) Поливалентная вакцина против hyo и ее применение
MX2020006662A (es) Vacuna combinada intradermica contra mycoplasma y circovirus porcino.
CL2008003845A1 (es) Vacuna que comprende una emulsion, una bacterina tratada termicamente a 55-70°c por 5-10 horas, que comprende una suspension de bacterias muertas de la especie leptospira bratislava, y de 1 a 13 virus causantes de enfermedad porcina.
BR112018069100A2 (pt) uma vacina combinada contra a infecção por vírus pcv2 e mycoplasma hyopneumoniae
BRPI0608310A2 (pt) uso de um poxvìrus modificado para a indução rápida de imunidade contra um poxvìrus ou outros agentes infecciosos
JP2019509300A5 (es)
MX2022012527A (es) Vacunas, adjuvantes, y metodos para generar una respuesta inmunitaria.
BR112022019207A2 (pt) Composições de vacina para coronavírus e métodos de uso das mesmas
CA2931139A1 (en) Swine vaccine against prrs and lawsonia intracellularis
BR112016012435A8 (pt) vacina, e, usos de uma proteína orf2 recombinantemente expressada do circovírus porcino tipo 2
WO2019068905A3 (en) Feline vaccines conferring early protection
MX2019012220A (es) Vacunas que contienen patogenos de cerdo para uso no mixto asociado.
MX2022013080A (es) Una combinacion de vacunas para el tratamiento profilactico de un cerdo.
RU2018137033A (ru) Вакцина для внутрикожного применения против инфекции вируса pcv2 и prrs
DK1387693T3 (da) Saponininaktiveret mykoplasmavaccine
BR112017004703A2 (pt) ?vacina e método para proteção de progênie de uma porca contra infeccção por um vírus de diarreia endêmica suína?